News

Domainex secures a prestigious King's Award for Enterprise

Domainex is honoured to announce it has received a King’s Award for Enterprise: International Trade 2023.

Cambridge and Saffron Walden, UK, 21st April 2023 / Sciad Newswire / Domainex is honoured to announce it has received a King’s Award for Enterprise: International Trade 2023. This prestigious award recognises the company’s outstanding growth in international trade over three years (2019-2021) which amounted to a more than one hundred per cent increase in international revenues during the period. This growth was achieved organically, coincided with the challenging backdrop of the COVID-19 pandemic and is a testament to the company’s excellent reputation and commitment to delivering high-quality drug discovery services for its life science clients. 

 
The King’s Award for Enterprise was previously known as the Queen’s Award for Enterprise. It was recently renamed following the accession of King Charles III, reflecting His Majesty the King’s desire to continue promoting outstanding UK businesses. The 2023 Awards are announced today, marking the late Queen Elizabeth II’s birthday.
 
The company continues to grow strongly and to invest in new talent, expanding its state-of-the-art facilities, deploying cutting-edge instrumentation, broadening its reach into new markets and giving its people opportunities to develop their careers and enjoy generous benefits. Since 2021, Domainex’s headcount has increased by over fifty per cent. In 2022, Domainex worked with a record number of clients in over a dozen countries (including the USA, Australia, Japan, Israel and several European countries). For the past two years, the company has achieved record overall levels of revenues. Additionally, Domainex has recently opened a new sales office in Cambridge, Massachusetts, demonstrating its continued commitment to international growth. 
 
Dr Tom Mander, CEO of Domainex, commented, “We are delighted to have been recognised with this highly prestigious award. Our growth is attributable to the hard work and dedication of the whole team and is especially valued as it was achieved during the challenging period of the COVID-19 pandemic. Our scientists regularly receive glowing feedback from our clients for their innovation and customer focus. This is at the heart of why we remain a pioneer in drug discovery research services, and I dedicate this award to them. I would also like to thank our board and current investors as this award would not have been possible without their continuing support.”
 
The award follows Domainex’s recent success at several awards events in 2022, including at the Cambridge Independent SME awards (Gold award for High Growth Business of the Year and Silver award for Business of the Year - more than 50 employees) and the SME National Business Awards (Silver award for High Growth Business of the Year). 
 

Share this article

More services

 

This article is featured in:
Companies and People

 

Comment on this article

You must be registered and logged in to leave a comment about this article.